Human Health Holdings Limited (HKG:1419)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.7600
0.00 (0.00%)
Nov 10, 2026, 11:22 AM HKT

Human Health Holdings Cash Flow Statement

Millions HKD. Fiscal year is Jul - Jun.

Operating Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Net Income
27.1326.3424.19180.84375.31
Depreciation & Amortization
66.967.7168.0174.7963.07
Loss (Gain) From Sale of Assets
-0.060.08-0.010.31-0.03
Asset Writedown & Restructuring Costs
3.1111.6118.7363.1510
Loss (Gain) From Sale of Investments
9.4-2.28-16.586.27-25.52
Loss (Gain) on Equity Investments
-0.20.241.271.541.98
Stock-Based Compensation
---0.010.07
Provision & Write-off of Bad Debts
-0.17-0.23-0.770.191.1
Other Operating Activities
24.63-0.6-102.0610.1964.5
Change in Accounts Receivable
12.99-13.8158.7320.52-189.95
Change in Inventory
6.86.68-4.42-9.92-4.43
Change in Accounts Payable
-10.6812.1-5.7216.986.18
Change in Unearned Revenue
-4.3-3.62-8.3523.39-1.68
Change in Other Net Operating Assets
8.43-5.61-19.79-24.01-4.79
Operating Cash Flow
143.9798.613.21664.26295.81
Operating Cash Flow Growth
46.02%646.60%-98.01%124.55%246.01%

Investing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Capital Expenditures
-8.03-7.77-39.51-84.02-76.52
Sale of Property, Plant & Equipment
0.22-0.02-0.14
Cash Acquisitions
--33.81-0.06-
Sale (Purchase) of Real Estate
-----26.34
Investment in Securities
-88.9345.48-7.34-250.13-100.14
Other Investing Activities
1.33-0.18-0.8-1.25-0.36
Investing Cash Flow
-95.413.71-47.64-335.34-203.22

Financing Activities

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Short-Term Debt Issued
20.6---35.52
Total Debt Issued
20.6---35.52
Short-Term Debt Repaid
-1.48-23.43-4.97-5.71-4.96
Long-Term Debt Repaid
-56.64-54.53-50.97-50.78-49.63
Lease Payments
-56.64-54.53-50.97-50.78-49.63
Total Debt Repaid
-58.12-77.96-55.94-56.49-54.59
Net Debt Issued (Repaid)
-37.52-77.96-55.94-56.49-19.07
Common Dividends Paid
-12.42-10.63-60.73-113.86-45.55
Other Financing Activities
-6.28-6.34-7.86-7.93-2.83
Financing Cash Flow
-56.22-94.93-124.52-178.29-67.45

Net Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Foreign Exchange Rate Adjustments
0.350.12-0.06-1.26-0.17
Net Cash Flow
-7.37.5-159.01149.3824.97

Free Cash Flow

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Free Cash Flow
135.9590.83-26.3580.24219.3
Free Cash Flow Growth
49.67%--164.59%206.97%
Free Cash Flow Margin
20.24%14.09%-4.45%57.92%19.55%
Free Cash Flow Per Share
0.360.24-0.071.530.58
Levered Free Cash Flow
102.5455.1-61.9528.29131.96
Unlevered Free Cash Flow
106.659.2-56.76533.47133.8
Free Cash Flow After Leases
79.3136.3-77.27529.46169.67

Additional Metrics

Fiscal Year
FY 2026FY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash Interest Paid
6.286.347.867.932.83
Cash Income Tax Paid
-15.4810.5112.1255.44.89
Change in Working Capital
13.24-4.2620.43326.97-194.66